Breast Cancer and Chemo-amennorhea

Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01867229

Acronym

chemo-ameno

Enrollment

Registered

2013-06-03

Start date

2011-10-31

Completion date

2014-12-31

Last updated

2019-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

pre-menauposal, neo-adjuvant or adjuvant chemotherapy, no metastases

Brief summary

Relation between chemotherapy and amennorhea

Interventions

OTHERobservational

standard of care fore patients with non metastatic breast cancer

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

pre-menauposal breast cancer needed to be treat with chemotherapy -

Exclusion criteria

metastases menopausal \-

Design outcomes

Primary

Measure	Time frame
incidence and duration of the amenorrhea induced by chemotherapy	5 years

Countries

Belgium, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026